NOVOCURE LTD's ticker is and the CUSIP is 67011XAB9. A total of 24 filers reported holding NOVOCURE LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,074,016 | -68.6% | 4,750,000 | -68.3% | 0.18% | -58.4% |
| Q1 2023 | $12,980,000 | +16.9% | 15,000,000 | +20.0% | 0.44% | +27.1% |
| Q4 2022 | $11,103,750 | -24.5% | 12,500,000 | -24.2% | 0.35% | -23.4% |
| Q3 2022 | $14,708,000 | +9.2% | 16,500,000 | +6.5% | 0.46% | +6.8% |
| Q2 2022 | $13,466,000 | +47.6% | 15,500,000 | +55.0% | 0.43% | +112.9% |
| Q1 2022 | $9,125,000 | – | 10,000,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DeepCurrents Investment Group LLC | 46,391,000 | $42,604,000 | 1.32% |
| Lombard Odier Asset Management (Europe) Ltd | 171,980 | $15,871,000 | 0.70% |
| WOLVERINE ASSET MANAGEMENT LLC | 80,367,000 | $73,232,000 | 0.68% |
| SHENKMAN CAPITAL MANAGEMENT INC | 6,419,000 | $5,736,000 | 0.39% |
| LINDEN ADVISORS LP | 63,485,000 | $58,560,000 | 0.36% |
| Ionic Capital Management LLC | 3,000,000 | $2,771,000 | 0.35% |
| SSI INVESTMENT MANAGEMENT LLC | 5,859,000 | $5,354,000 | 0.31% |
| Verition Fund Management LLC | 33,485,000 | $30,766,000 | 0.22% |
| Nicholas Investment Partners, LP | 3,550,000 | $3,244,000 | 0.20% |
| TFG Asset Management GP Ltd | 3,000,000 | $2,769,000 | 0.17% |